Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001649989-26-000003

Director bought 34,000 shares at $0.44 ($14,960)

From the SEC's structured data for this filing

Trades in this filing

Haddadin Yezan Munther · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-05-26 Purchase : show line 1 in the form +34,000 $0.44 $14,960 37,167 D
Open-market purchases · 34,000 sh · avg $0.44 · $14,960
Loading xslF345X06/primary_doc.xml…